Medicines and Healthcare Products Regulatory Agency donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

We do not have any donee information for the donee Medicines and Healthcare Products Regulatory Agency in our system.

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 5 1,206,658 998,046 78,660 78,660 78,660 299,941 299,941 1,206,658 1,206,658 1,308,530 1,308,530 2,096,442 2,096,442
Global health 5 1,206,658 998,046 78,660 78,660 78,660 299,941 299,941 1,206,658 1,206,658 1,308,530 1,308,530 2,096,442 2,096,442

Donation amounts by donor and year for donee Medicines and Healthcare Products Regulatory Agency

Donor Total 2017 2015 2014 2013 2011
Bill and Melinda Gates Foundation (filter this donee) 4,990,231.00 1,308,530.00 1,206,658.00 299,941.00 78,660.00 2,096,442.00
Total 4,990,231.00 1,308,530.00 1,206,658.00 299,941.00 78,660.00 2,096,442.00

Full list of documents in reverse chronological order (0 documents)

There are no documents associated with this donee.

Full list of donations in reverse chronological order (5 donations)

Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations

Graph of donations and their timeframes
DonorAmount (current USD)Amount rank (out of 5)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation1,308,530.0022017-10-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build sustainable capacity in pharmacovigilance in the low and middle income country settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified|Africa|South America|Asia.
Bill and Melinda Gates Foundation1,206,658.0032015-08-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to assess strategy combinations to achieve the goal of an improved oral polio vaccine OPV-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation299,941.0042014-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to assess strategy combinations to achieve the goal of an improved oral polio vaccine OPV-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation78,660.0052013-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to assess strategy combinations to achieve the goal of an improved oral polio vaccine OPV-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,096,442.0012011-11-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to assess strategy combinations to achieve the goal of an improved oral polio vaccine OPV-2; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.